TASHA CHAPA: Open Payments
NPI 1225707144 · PALO, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$491 in 25 payments from 9 companies in 2025. Trend: 2023 $1,133 · 2024 $667 · 2025 $491
Food & beverage: $491
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $143 |
| PFIZER INC. | 5 | $92 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $76 |
| Novartis Pharmaceuticals Corporation | 3 | $50 |
| AstraZeneca Pharmaceuticals LP | 3 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| E.R. Squibb & Sons, L.L.C. | 2 | $29 |
| Abbott Laboratories | 1 | $14 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $11 |
Products named: REPATHA, Kerendia, VYNDAQEL, LEQVIO, FARXIGA, ELIQUIS, JARDIANCE, CARDIOMEMS.
Industry payments across IA — which companies pay providers there.
